The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Kit Research for Tissue Repair Pathways Hydration Room FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) GHK CU BPC 157 TB 500 ANTI AGING BLEND LUX LAB TB 500 BPC 157 GHK Cu (10 10 50 MG) Sigma Compounds